GH
Guardant Health, Inc.Company Information
- Company Name
- Guardant Health, Inc.
- CIK
- CIK0001576280
- Category
- Large accelerated filer
- Ticker: Exchange
- GH: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8071
- SIC Description
- Services-Medical Laboratories
- Ticker
- GH
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-15
- Last sale
- 2026-06-29
- Shares purchased (TTM)
- 600
- Shares sold (TTM)
- 1,482,499
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 124,591,853
- Shares outstanding
- 131,273,000
- Ownership
- 94.91%
Earnings Market Reaction
- Filing date
- 2026-07-30
- Price on filing date
- —
- 1-month reaction
- Pending
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1,053 | 989 | 378 | 580 | 629 | 699 | 526 | 688 | 1,035 | 1,129 | 1,134 | 457 | ||||||
| Available For Sale Securities Debt Securities Current | 0 | 113 | 823 | 0 | 0 | 0 | 314 | 311 | 0 | 0 | 35 | 697 | ||||||
| Accounts Receivable Net Current | 144 | 137 | 138 | 116 | 130 | 115 | 110 | 88 | 101 | 85 | 89 | 89 | ||||||
| Inventory Net | 105 | 84 | 86 | 90 | 84 | 77 | 71 | 72 | 67 | 63 | 62 | 77 | ||||||
| Prepaid Expense And Other Assets Current | 61 | 43 | 41 | 43 | 40 | 36 | 34 | 67 | 87 | 32 | 28 | 26 | ||||||
| Assets Current | 1,365 | 1,368 | 1,466 | 829 | 883 | 927 | 1,055 | 1,227 | 1,290 | 1,309 | 1,347 | 1,347 | ||||||
| Restricted Cash Noncurrent | 114 | 112 | 111 | 110 | 106 | 105 | 104 | 103 | 102 | 100 | 0 | - | ||||||
| Property Plant And Equipment Net | 155 | 150 | 146 | 125 | 126 | 129 | 137 | 125 | 132 | 138 | 145 | 148 | ||||||
| Operating Lease Right Of Use Asset | 148 | 154 | 159 | 164 | 170 | 141 | 142 | 145 | 146 | 152 | 158 | 162 | ||||||
| Intangible Assets Net Excluding Goodwill | 25 | 26 | 26 | 5 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 10 | ||||||
| Goodwill | 77 | 77 | 77 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Other Assets Noncurrent | 28 | 29 | 28 | 41 | 37 | 33 | 37 | 31 | 30 | 94 | 124 | 128 | ||||||
| Assets | 1,912 | 1,915 | 2,014 | 1,277 | 1,332 | 1,344 | 1,486 | 1,539 | 1,609 | 1,705 | 1,786 | 1,797 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | 188 | 205 | ||||||
| Accounts Payable Current | 94 | 75 | 54 | 20 | 45 | 50 | 39 | 15 | 42 | 38 | 52 | - | ||||||
| Accrued Employee Benefits Current | 121 | 91 | 120 | 98 | 68 | 64 | 83 | 81 | 59 | 93 | 73 | - | ||||||
| Accrued Liabilities Current | 79 | 78 | 78 | 72 | 71 | 76 | 68 | 72 | 71 | 67 | - | - | ||||||
| Other Accrued Liabilities Current | - | - | 78 | - | - | - | 68 | - | - | - | 63 | - | ||||||
| Contract With Customer Liability Current | 45 | 48 | 51 | 47 | 54 | 36 | 35 | 30 | 29 | 23 | 18 | 21 | ||||||
| Liabilities Current | 339 | 292 | 303 | 237 | 238 | 226 | 226 | 197 | 202 | 220 | 206 | 227 | ||||||
| Convertible Debt Noncurrent | 1,503 | 1,503 | 1,504 | 1,115 | 1,116 | 1,116 | 1,143 | 1,142 | 1,141 | 1,141 | 1,140 | 1,139 | ||||||
| Operating Lease Liability Noncurrent | 166 | 173 | 178 | 185 | 192 | 160 | 164 | 170 | 172 | 179 | 186 | 193 | ||||||
| Other Liabilities Noncurrent | 127 | 128 | 128 | 94 | 91 | 93 | 93 | 89 | 96 | 97 | 96 | 10 | ||||||
| Liabilities | 2,135 | 2,096 | 2,113 | 1,631 | 1,637 | 1,595 | 1,625 | 1,599 | 1,611 | 1,636 | 1,628 | 1,569 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Value | - | - | - | -45 | -45 | -45 | - | - | - | - | - | - | ||||||
| Additional Paid In Capital | 3,009 | 2,931 | 2,900 | 2,561 | 2,517 | 2,472 | 2,444 | 2,410 | 2,364 | 2,330 | 2,304 | 2,189 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -6 | -5 | -5 | -4 | -4 | -5 | -5 | -3 | -6 | -5 | -4 | -6 | ||||||
| Retained Earnings Accumulated Deficit | -3,227 | -3,107 | -2,995 | -2,866 | -2,773 | -2,673 | -2,578 | -2,467 | -2,359 | -2,257 | -2,142 | -1,955 | ||||||
| Stockholders Equity | -223 | -181 | -99 | -354 | -305 | -251 | -140 | -60 | -2 | 68 | 159 | 228 | ||||||
| Liabilities And Stockholders Equity | 1,912 | 1,915 | 2,014 | 1,277 | 1,332 | 1,344 | 1,486 | 1,539 | 1,609 | 1,705 | 1,786 | 1,797 | ||||||
| Debt Instrument Face Amount | - | - | - | 1,091 | 1,091 | 1,091 | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | ||||||
| Common Stock Shares Issued | 134 | 132 | 131 | 126 | 125 | 125 | 124 | 123 | 123 | 122 | 122 | 118 | ||||||
| Shares Outstanding | 134 | 132 | 131 | 125 | 124 | 124 | 124 | 123 | 123 | 122 | 122 | 118 | ||||||
| Treasury Stock Common Shares | - | - | - | 1 | 1 | 1 | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGuardant Health, Inc. (GH) — SEC Financial Statements & Analysis
Guardant Health, Inc. (GH) is a services-medical laboratories company, incorporated in DE. Guardant Health, Inc. trades on Nasdaq as: GH. Guardant Health, Inc. (GH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, Guardant Health, Inc. carries a market cap of $19.93B, a P/E ratio of -43.96x, a P/B ratio of -89.44x, a P/S ratio of 16.85x, an enterprise value of $20.27B, and an EV/EBITDA multiple of -46.94x. On profitability, it posts a gross margin of 65.01%, an operating margin of -39.75%, a net margin of -38.33%, a Return on Equity (ROE) of 171.64%, a Return on Assets (ROA) of -27.95%, and a Return on Invested Capital (ROIC) of -413.12%. Per share, it reports EPS of $-3.41, diluted EPS of $-3.41, free cash flow per share of $-1.81, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 42.74% year-over-year, net income growth of 9.57% year-over-year, and EPS growth of 2.36% year-over-year. On the balance sheet, it maintains a current ratio of 4.03x, a quick ratio of 3.53x, working capital of $1.03B, a debt-to-equity ratio of -9.58x, a debt ratio of 1.12, an interest coverage ratio of -97.65x, free cash flow of $-240.72M (TTM), and net debt of $335.20M. Figures sourced from SEC EDGAR.
- Market Cap
- $19.93B
- P/E TTM
- -43.96x
- EPS TTM
- $-3.41
- P/B TTM
- -89.44x
- ROE TTM
- 171.64%
- ROA TTM
- -27.95%
- Debt To Equity
- -9.58x
- Free Cash Flow TTM
- $-240.72M
- Net Revenue TTM Growth 1Y
- 42.74%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Guardant Health, Inc. in?
Guardant Health, Inc. (GH) operates in the Services-Medical Laboratories industry.
What exchange does GH trade on?
Guardant Health, Inc. (GH) trades on the Nasdaq.
Where is Guardant Health, Inc. incorporated?
Guardant Health, Inc. is incorporated in DE.
When was Guardant Health, Inc. (GH)'s most recent SEC filing?
Guardant Health, Inc. (GH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30.
What is GH's market cap?
Guardant Health, Inc. (GH) has a market capitalization of $19.93B as of 2026-06-30.
What is GH's EPS (earnings per share)?
Guardant Health, Inc. (GH)'s trailing twelve month EPS is $-3.41 as of 2026-06-30.
What is GH's ROE (return on equity)?
Guardant Health, Inc. (GH)'s trailing twelve month Return on Equity (ROE) is 171.64% as of 2026-06-30.
What is GH's ROA (return on assets)?
Guardant Health, Inc. (GH)'s trailing twelve month Return on Assets (ROA) is -27.95% as of 2026-06-30.
What is GH's ROIC (return on invested capital)?
Guardant Health, Inc. (GH)'s trailing twelve month Return on Invested Capital (ROIC) is -413.12% as of 2026-06-30.
What is GH's EV/EBITDA?
Guardant Health, Inc. (GH)'s trailing twelve month EV/EBITDA is -46.94x as of 2026-06-30.